Urothelial cancer proteomics provides both prognostic and functional information.

导出 LinkOut

翻译打印收藏纠错

第一作者： Guillermo,de Velasco

第一单位： Department of Medical Oncology, University Hospital 12 de Octubre, i + 12, Madrid, Spain. gdvelasco.gdv@gmail.com.

作者： Guillermo,de Velasco ^[1] ; Lucia,Trilla-Fuertes ^[2] ; Angelo,Gamez-Pozo ^[3] ; Maria,Urbanowicz ^[2] ; Gustavo,Ruiz-Ares ^[3] ; Juan M,Sepúlveda ^[4] ; Guillermo,Prado-Vazquez ^[5] ; Jorge M,Arevalillo ^[5] ; Andrea,Zapater-Moros ^[2] ; Hilario,Navarro ^[6] ; Rocio,Lopez-Vacas ^[2] ; Ray,Manneh ^[6] ; Irene,Otero ^[2] ; Felipe,Villacampa ^[5] ; Jesus M,Paramio ^[5] ; Juan Angel Fresno,Vara ^[7] ; Daniel,Castellano ^[8]

作者单位： Department of Medical Oncology, University Hospital 12 de Octubre, i + 12, Madrid, Spain. gdvelasco.gdv@gmail.com. ^[1] Molecular Oncology & Pathology Lab, INGEMM, Instituto de Investigación Hospital La Paz-IdiPAZ, Madrid, Spain. ^[2] Biomedica Molecular Medicine, Madrid, Spain. ^[3] Department of Pathology, University Hospital 12 de Octubre, Madrid, Spain. ^[4] Department of Medical Oncology, University Hospital 12 de Octubre, i + 12, Madrid, Spain. ^[5] Department of Statistics, Operational Research and Numerical Analysis, University Nacional Educacion a Distancia (UNED), Madrid, Spain. ^[6] Department of Urology, University Hospital 12 de Octubre, Madrid, Spain. ^[7] CIBERONC, Madrid, Spain. ^[8] Molecular and Cell Oncology Group, Biomedical research Institute, University Hospital 12 de Octubre, i + 12, and Molecular Oncology Unit, CIEMAT, Madrid, Spain. ^[9]